Abstract
We describe the case of a patient with refractory bipolar II depression who developed tolerance to lamotrigine and after failing to respond to dose escalation showed a robust response to a retrial of lamotrigine following a two week drug holiday.
Keywords: Lamotrigine, Bipolar II depression, Bipolar II disorder, Tolerance, Drug holiday, Retrial
Letters in Drug Design & Discovery
Title: A Novel Strategy to Manage Tolerance to Lamotrigine in Bipolar II Depression
Volume: 5 Issue: 4
Author(s): V. Sharma and C. Corpse
Affiliation:
Keywords: Lamotrigine, Bipolar II depression, Bipolar II disorder, Tolerance, Drug holiday, Retrial
Abstract: We describe the case of a patient with refractory bipolar II depression who developed tolerance to lamotrigine and after failing to respond to dose escalation showed a robust response to a retrial of lamotrigine following a two week drug holiday.
Export Options
About this article
Cite this article as:
Sharma V. and Corpse C., A Novel Strategy to Manage Tolerance to Lamotrigine in Bipolar II Depression, Letters in Drug Design & Discovery 2008; 5 (4) . https://dx.doi.org/10.2174/157018008784619924
DOI https://dx.doi.org/10.2174/157018008784619924 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurokinin-1 (NK<sub>1</sub>) receptor antagonists as possible therapeutics for psychostimulant use disorders
CNS & Neurological Disorders - Drug Targets Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Current Medicinal Chemistry Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer`s and Parkinson`s Diseases
Mini-Reviews in Medicinal Chemistry Molecular and Genetic Mechanisms of Osteoporosis: Implication for Treatment
Current Molecular Medicine The Wnt Pathway: Emerging Anticancer Strategies
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton’s Jelly Cells
Recent Patents on Regenerative Medicine Synthesis and Biological Evaluation of Curcumin-Nitroxide-Based Molecular Hybrids as Antioxidant and Anti-Proliferative Agents
Medicinal Chemistry Structure-Activity Relationships of Histamine H1-Receptor Agonists
Mini-Reviews in Medicinal Chemistry Animal Models of Xenobiotic Receptors
Current Drug Metabolism Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Current Drug Targets How Do HIV-Infected Smokers React to Cigarette Price Increases? Evidence from the Aproco-Copilote-ANRS CO8 Cohort
Current HIV Research Image Based Brain Segmentation: From Multi-Atlas Fusion to Deep Learning
Current Medical Imaging High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?
Current Medicinal Chemistry The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies
Current Drug Targets Author Index to Volume 1
Current Neurovascular Research Role of Nitrosative Stress and Activation of Poly(ADP-ribose) Polymerase-1 in Cardiovascular Failure Associated with Septic and Hemorrhagic Shock
Current Vascular Pharmacology Intracranial Collateral Flow Estimated by Color Velocity Imaging Quantification Ultrasound: A Protector of Recurrent Stroke in Patient with Carotid Stenosis?
Current Neurovascular Research Methamphetamine Induces Striatal Cell Death Followed by the Generation of New Cells and a Second Round of Cell Death in Mice
Current Neuropharmacology The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Current Neuropharmacology